Yasons Chemex Care reports revenue rise in FY26

1 min read     Updated on 27 Jun 2026, 03:46 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Yasons Chemex Care reported a net profit of ₹93.78 lakh for FY26, with revenue increasing to ₹7,125.78 lakh. Consolidated net profit stood at ₹93.83 lakh on revenue of ₹9,681.93 lakh. The Board approved the audited results on May 29, 2026, and statutory auditors issued an unmodified opinion.

powered bylight_fuzz_icon
44100958

*this image is generated using AI for illustrative purposes only.

Yasons Chemex Care reported a net profit of ₹93.78 lakh for the financial year ended March 31, 2026, a decline from ₹161.17 lakh in the previous year. Revenue from operations rose to ₹7,125.78 lakh in FY26 from ₹4,583.91 lakh in FY25. The company's Board of Directors approved the audited standalone and consolidated financial results for the half year and the financial year ended March 31, 2026, at a meeting held on May 29, 2026.

Financial Performance

The company's total income for the year stood at ₹7,364.59 lakh, up from ₹4,802.15 lakh in the prior year. Total expenses increased to ₹7,239.89 lakh from ₹4,611.42 lakh. For the half year ended March 31, 2026, the company reported a net loss of ₹7.55 lakh, compared to a profit of ₹3.04 lakh in the same period of the previous year.

Consolidated Results

On a consolidated basis, which includes subsidiary Rishit Polysurf LLP, the company reported a net profit of ₹93.83 lakh for FY26, compared to ₹162.08 lakh in FY25. Consolidated revenue from operations increased to ₹9,681.93 lakh from ₹7,653.31 lakh in the previous year. Total consolidated income for the year was ₹10,059.31 lakh.

Key Metrics

Metric FY26 (₹ in Lakhs) FY25 (₹ in Lakhs)
Standalone Revenue 7,125.78 4,583.91
Standalone Net Profit 93.78 161.17
Consolidated Revenue 9,681.93 7,653.31
Consolidated Net Profit 93.83 162.08
Total Expenses 7,239.89 4,611.42

Audit and Compliance

The statutory auditors, M/s H S K & CO LLP, issued an audit report with an unmodified opinion on the standalone and consolidated financial results. The auditors confirmed that the results are presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The company also confirmed that funds raised from its Initial Public Offer totaling ₹2,056.80 lakh were utilized as per the objects disclosed in the offer document, with an unutilized amount of ₹0.32 lakh.

Historical Stock Returns for Yasons Chemex Care

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+17.30%+7.43%-5.65%-13.55%-67.71%

What specific factors drove the significant increase in expenses despite the rise in revenue?

How does the company plan to improve profit margins in the upcoming financial year?

What strategic initiatives will be implemented to address the net loss reported in the second half of FY26?

Yasons Chemex Care Limited Submits SDD Compliance Certificate for Financial Year Ended 31st March 2026

1 min read     Updated on 12 May 2026, 09:51 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Yasons Chemex Care Limited submitted its Structured Digital Database (SDD) Compliance Certificate for the financial year ended 31st March 2026 to the National Stock Exchange of India Limited on 11th May 2026. The certificate was issued by CS Kunal Sharma of Kunal Sharma & Associates under Regulation 3(5) and 3(6) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. All seven required UPSI events during the financial year were confirmed as captured in the database, which is maintained in a non-tamperable format with an audit trail and a record retention capability of eight years.

powered bylight_fuzz_icon
40105277

*this image is generated using AI for illustrative purposes only.

Yasons Chemex Care Limited filed its Structured Digital Database (SDD) Compliance Certificate for the financial year ended 31st March 2026 with the Listing Department of the National Stock Exchange of India Limited on 11th May 2026. The filing was made pursuant to Regulation 3(5) and Regulation 3(6) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations). The submission was signed by Pritesh Yashwantlal Shah, Managing Director of the company, on behalf of Yasons Chemex Care Limited.

SDD Compliance Certificate Details

The compliance certificate was issued by CS Kunal Sharma, Proprietor of Kunal Sharma & Associates, Company Secretaries, Ahmedabad, who was appointed as the Practising Company Secretary by Yasons Chemex Care Limited. The certificate confirms that the company has fulfilled all applicable requirements under the SEBI PIT Regulations for the financial year ended 31st March 2026.

The following key compliance points were certified:

Compliance Parameter: Status
Structured Digital Database in place Confirmed
Access control to SDD Confirmed
All UPSI disseminated during FY captured Confirmed
Nature of UPSI, date and time captured Confirmed
Database maintained internally with audit trail Confirmed
Database non-tamperable, records maintained for 8 years Confirmed
Number of events required to be captured Seven (7)
Number of events actually captured Seven (7)

Certifying Authority

The certificate was issued by CS Kunal Sharma of Kunal Sharma & Associates, Company Secretaries, based in Ahmedabad. The relevant professional credentials of the certifying authority are as follows:

  • Membership Number: FCS 10329
  • Certificate of Practice Number: 12987
  • PR No: 1933/2022
  • UDIN: F010329H000326117
  • Date of Certification: 11th May 2026
  • Place: Ahmedabad

About the Filing

Yasons Chemex Care Limited, incorporated with CIN U24304GJ2017PLC099511, is engaged in the manufacturing of perfumes, deodorants, dyestuff, and trading of all kinds of chemicals. Its registered office is located at 4th Floor, 412 Sigma Icon-1, 132ft Ring Road, Opp. Medilink Hospital, Satellite, Ahmedabad – 380015. The SDD compliance filing underscores the company's adherence to regulatory obligations under the SEBI framework governing the prohibition of insider trading.

Historical Stock Returns for Yasons Chemex Care

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+17.30%+7.43%-5.65%-13.55%-67.71%

How might Yasons Chemex Care's consistent SDD compliance record influence investor confidence and potentially attract institutional investors to the stock?

With seven UPSI events captured in FY2026, could an increase in material non-public information disclosures signal upcoming significant corporate actions such as mergers, expansions, or fundraising activities?

As SEBI continues to tighten insider trading regulations, what additional compliance infrastructure investments might small-cap chemical companies like Yasons Chemex Care need to make in coming years?

More News on Yasons Chemex Care

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-13.55%